Key takeaways:
Radiation therapy is a standard treatment for prostate cancer.
For people with localized prostate cancer, radiation therapy is as effective as surgery. The side effects of radiation therapy are usually mild.
There are several types of radiation therapy. The right type depends on how your prostate cancer behaves and responds to treatment.
There are many treatments for prostate cancer. Along with surgery, radiation therapy is a standard treatment for prostate cancer that hasn’t spread to other parts of your body. Radiation therapy may also be an option for people who have more advanced forms of prostate cancer.
To help you navigate the process, we’ll cover how radiation therapy works, and the different types used for prostate cancer. We’ll also look at possible side effects and how well radiation therapy works. Read on to see how radiation therapy might fit into your prostate cancer treatment.
Radiation therapy uses X-rays, radioactive particles, or radioactive materials to treat cancer. It kills cancer cells by damaging their DNA, or genetic material. When the DNA is damaged, cancer cells can’t divide. If they try to divide, they die.
Radiation therapy can also affect healthy cells nearby. But new technology allows radiation oncologists to deliver radiation therapy with more precision. This helps lower the risk of damage to healthy tissue.
There are many types of radiation therapy that can help treat prostate cancer. But not all treatments work for everyone. The right treatment depends on your specific situation.
Here are some of the most commonly used radiation treatments for prostate cancer right now.
In external beam radiation therapy (EBRT), radiation therapy is delivered to the prostate gland from outside of your body.
There are several types of EBRT, including:
Intensity-modulated radiation therapy (IMRT): IMRT delivers high doses of radiation to cancer cells while minimizing harm to healthy cells
Stereotactic body radiation therapy (SBRT): Compared with IMRT, SBRT delivers higher doses of radiation with high precision during each treatment session. Because of this, fewer treatment sessions are needed with SBRT.
Proton therapy: Proton therapy uses charged energy particles to treat cancer cells.
Before starting EBRT, radiation oncologists often place metallic markers in the prostate gland. This helps them aim the radiation with more precision. In some cases, a spacer is also placed between the prostate and rectum. This helps to prevent damage to the rectum.
Getting started: Our prostate cancer guide can help you find the answers you need.
What is a prostatectomy? Review the types of surgery used to treat prostate cancer.
Prostate cancer staging: Prostate cancer staging is the first step to cancer treatment. Here’s how to decode your prostate cancer stage.
In brachytherapy, radiation therapy is delivered to the prostate cancer from inside your body. A radiation oncologist places radioactive material directly into the prostate gland. There are two main types of brachytherapy:
Low-dose rate (LDR) brachytherapy: The radioactive material stays in your body after treatment.
High-dose rate (HDR) brachytherapy: The radioactive material stays in your body for only a few minutes during each session and then removed.
Radiopharmaceuticals are medications that deliver radiation directly to cancer cells. 177Lu-PSMA-617 (Pluvicto) is a radiopharmaceutical that is FDA-approved to treat metastatic prostate cancer that no longer responds to hormone therapy (also called metastatic castration-resistant prostate cancer) and whose tumors have enough PSMA protein.
Radium-223 (Xofigo) is another FDA-approved radiopharmaceutical that treats advanced prostate cancer that has spread to the bones.
Radiation therapy’s effectiveness depends on your situation. In general, radiation therapy is a very effective treatment for people with localized prostate cancer. In fact, radiation therapy and surgery have similar results.
A large clinical trial recently looked at different treatments for prostate cancer. People in the study were randomly assigned to surgery, radiation therapy, or active monitoring. After 10 years, survival rates were similar for all three groups. But people in the active monitoring group were more likely to have cancer spread to their bones. Among all groups, fewer than 1 in 50 people died from prostate cancer after 10 years.
After treatment, the healthcare team uses a blood test called prostate-specific antigen (PSA) to make sure people responded to treatment and look for signs that the cancer might come back. If the PSA starts to increase after treatment, it’s called “biochemical recurrence.”
Studies have shown that the rate of biochemical recurrence is low after radiation therapy:
Less than 10% for low-risk prostate cancer
Between 10% and 15% for intermediate-risk prostate cancer
Between 15% and 20% for high-risk prostate cancer
There isn’t one standard course of prostate radiation therapy.
But here’s what it might look like:
Intensity modulated radiation (IMRT): People usually get treatment 5 days a week for 4 to 6 weeks. Each session lasts up to 30 minutes.
Stereotactic body radiation therapy (SBRT): Treatment may be given 3 to 5 times over 1 to 2 weeks. Some people need as few as 5 treatment sessions. Each session can last up to 1 hour.
Most of this time during these sessions is spent making sure your body is in the right position for treatment. The radiation beam is usually on for 3 to 5 minutes.
Brachytherapy usually takes just one or two sessions. Each session is done in an operating room under general anesthesia. Brachytherapy is usually an outpatient procedure, so you can go home the same day. The procedure usually takes 1 to 4 hours.
A radiation beam is invisible, and you won’t feel anything during treatment.
But during a course of prostate radiation, it’s common to have some side effects. These are usually mild, and severe side effects are rare. Common side effects include:
Fatigue
Frequent urination
Burning with urination
Weaker urinary stream
Diarrhea
Rectal irritation
More frequent bowel movements
Erectile dysfunction
Lower sperm production
Some of these side effects happen right away. Others might not show up until after you’ve finished therapy. Some of these side effects will go away over time, but others may be long-lasting.
It’s not always easy to predict who will have long-term side effects. But if they do happen, they’re usually manageable, and your care team can help.
Yes, you can drive yourself to EBRT treatment sessions. But you can’t drive yourself home after brachytherapy, since you’ll receive anesthesia. You shouldn’t drive or operate machinery for at least 24 hours after getting anesthesia.
Radiation therapy for prostate cancer may increase your risk of developing bladder or rectal cancer in the future, but this is rare. Radiation therapy may also lead to bone weakness in your pelvis.
If you receive EBRT, you don’t need to limit your contact with other people. You may need to limit contact with babies, young children, and those who are pregnant if you receive brachytherapy. It’s okay to be in the same room, but you may need to limit close contact like hugging and cuddling.
Sometimes, teams use androgen deprivation therapy (ADT) along with radiation therapy for prostate cancer. ADT reduces the risk that the cancer will spread. Specialists often recommend ADT for high-risk or unfavorable intermediate-risk cancers.
Radiation therapy is an effective treatment for prostate cancer. But treatment plans aren’t the same for everyone. To determine the best treatment plan for each person, healthcare teams consider several factors.
American Cancer Society. (2024). How radiation therapy is used to treat cancer.
Cancer Research UK. (2022). Long term side effects of prostate cancer radiotherapy.
Hamdy, F. C., et al. (2016). 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. The New England Journal of Medicine.
Hsu, I., et al. (2021). Long-term results of NRG Oncology/RTOG 0321: A Phase II trial of combined high dose rate brachytherapy and external beam radiation therapy for adenocarcinoma of the prostate. International Journal of Radiation Oncology, Biology, Physics.
Kishan, A. U., et al. (2022). Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: An individual patient data meta-analysis. The Lancet Oncology.
Krauss, D. J., et al. (2021). Dose escalated radiotherapy alone or in combination with short-term androgen suppression for intermediate risk prostate cancer: Outcomes from the NRG Oncology/RTOG 0815 randomized trial. International Journal of Radiation Oncology, Biology, Physics.